Discovery Stems From Here
Find your tools for building human cell-based models & screening assays
Welcome to Axol Bioscience
YOUR HUMAN CELL CULTURE SPECIALISTS
We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.
Introducing Axol's Global Head of Product Management26 November 2020Kimberly recently joined Axol Bioscience on November 12th as the Global Head of Product Management. Kimberly is a technically and scientifically astute marketing leader with 16 years of experience
Hiring Senior Scientist / Team Leader25 November 2020
Axol Bioscience is looking for an individual who has the same passion for science as we have, as we develop new innovate products and solutions for the fields of drug discovery, toxicology and life sciences. This is a unique opportunity to manage, lead and mentor a team of junior scientists and technicians in the expanding scientific operations team, as well as developing as an individual and contribute to Axol’s continued success.
Axol Bioscience Expanding Account Management Team24 November 2020
Axol Bioscience Expanding Account Management Team in the US
Introduction of MEA screening services for human iPSC-derived cells13 October 2020
Axol Bioscience today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells. The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models.
Axol Bioscience appoints Liam Taylor as Chief Executive Officer27 August 2020
Cambridge, UK, 26 August 2020: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam will guide the growth of the Company, and will focus on maximizing the potential of the team, and its iPSC (induced pluripotent stem cell) technologies, products and services.